Hwail Pharmaceutical Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hwail Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
CKD Bio Corp
sales of 113.01 billion Korean Won [US$99.90 million]
of which 100%
was Pharmaceutical Manufacturing),
Ctc Bio, Incorporation.
(123.15 billion Korean Won [US$108.86 million]
Samil Pharmaceutical Co., Ltd.
(96.76 billion Korean Won [US$85.53 million]
Hwail Pharmaceutical Company Limited reported sales of 111.52 billion Korean Won (US$98.58 million)
December of 2016.
increase of 5.1%
versus 2015, when the company's sales were 106.13 billion Korean Won.
Sales at Hwail Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 43%).